Compare HubSpot Inc (HUBS) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HubSpot Inc vs Regeneron Pharmaceuticals Inc — how do they compare? HubSpot Inc trades at $216.33 (market cap $11.00B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 7.5× HubSpot Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while HubSpot Inc pays none. Which is the better fit depends on your goals.
| HUBS | REGN | |
|---|---|---|
Market Cap | $11.00B | $82.06B |
Sector | Technology | Health |
52-Week High | $522.97 | $812.27 |
52-Week Low | $170.39 | $555.51 |
Enterprise Value | $9.89B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HubSpot Inc
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
Read more on HUBS →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
